Chandigarh-based Parabolic Drugs has entered into an agreement with a local company for manufacturing nutraceutical drugs in bulk. Talking about the deal, director Vineet Gupta told CNBC-TV18's Latha Venkatesh and Reema Tendulkar, "The intention is to use our facility on loan license basis and then develop and market our own products with the capacity in international markets."
Below is the verbatim transcript of the interview. Also watch the accompanying video. Q: What is the agreement that you have reached with a local company? A: The company has been manufacturing some nutraceutical products for a while. With Parabolic's capability in the international markets and the strength of our marketing team, our intention is to take the facility on loan-license basis. It is also to develop and market our own products. Q: How do the finances work? What is the name of this company? What is the capacity that you are loaning from them? What do you pay them? What do you expect to make? A: ItDiscover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
